# Review: Panel-Driven Research Quality Impact

**Reviewer**: Percy Liang (Stanford)
**Expertise**: Evaluation, benchmarks, foundations
**Round**: 1
**Date**: 2026-02-07

---

## Overall Assessment

This paper asks an important question: does structured AI peer review improve research quality beyond user-directed work? The +127% quality improvement is a strong result, and the within-project design is a reasonable experimental choice given practical constraints. However, as someone who works on rigorous evaluation and benchmarking (HELM), I have serious concerns about the **evaluation methodology**.

The core problem: **N=1 for the treatment condition**. The panel-driven corpus consists of a single paper, while the traditional corpus has three papers. This is insufficient for statistical inference, introduces selection bias (what if that one paper was just better?), and prevents any confidence interval estimation. The paper acknowledges this as a limitation, but then proceeds to make strong causal claims ("panel-driven research achieves +127% quality improvement") based on an N=1 comparison.

Second, the **10 quality dimensions** are reasonable but not validated. Who says these are the right dimensions? Were they chosen before or after seeing the papers (pre-registration)? What's the inter-rater reliability beyond the two raters in this study? Without validation, the quality scores are subjective assessments masquerading as objective metrics.

Third, the **process tracing** (git commits, session notes) provides valuable qualitative evidence, but the paper conflates correlation with causation. Yes, the panel-driven paper had 8+ feedback rounds and achieved breakthrough innovations. But we don't know if traditional papers would have achieved the same with 8+ user-directed iterations. The comparison confounds *review methodology* with *iteration count*.

That said, the **mechanistic analysis** (Section 5.1) is this paper's strongest contribution. Identifying four mechanisms—systematic questioning, embracing negatives, standards elevation, iteration forcing—provides actionable insights even if the quantitative evaluation is weak. If the paper reframed itself as a **case study with mechanistic hypotheses** rather than an empirical evaluation, I'd be more enthusiastic.

## Score

**Score**: 2/4 — Weak Accept (Major Revisions Required)

## Major Issues (Blocking)

### M1: N=1 Treatment Group Prevents Statistical Inference

The panel-driven corpus consists of **one paper**. The traditional corpus has three. This is insufficient for claiming "+127% quality improvement" with any statistical confidence. What if the VRA paper was inherently more interesting, complex, or well-suited to systematic exploration than the traditional papers, independent of review methodology?

**Problems**:
- No confidence intervals or error bars on the +127% estimate
- No statistical test (not possible with N=1)
- No control for paper-level confounds (problem complexity, inherent interestingness)
- Selection bias: Which paper was chosen for panel-driven treatment, and why?

**Required changes**:
- Reframe claims as **case study** rather than empirical evaluation
- Change abstract: "We present a case study comparing..." instead of "We demonstrate..."
- Remove or heavily qualify quantitative claims ("+127% improvement" → "In this case, we observe 127% improvement")
- Add explicit statement: "Statistical inference is not possible with N=1; findings should be treated as hypothesis-generating"
- Propose **experimental design** for future work: randomize M papers to traditional vs. panel, sufficient N for statistical tests

### M2: Quality Dimensions Not Validated

The 10 quality dimensions (Table 1, Section 3.2) are reasonable but **not validated**. Critical gaps:

- **Pre-registration**: Were dimensions chosen before analyzing papers, or post-hoc to favor panel-driven work?
- **Inter-rater reliability**: Cohen's κ=0.78 is reported for two raters (author + independent). What about a third rater? Five raters?
- **External validation**: Do these dimensions predict actual outcomes (publication acceptance, citation impact)?
- **Dimensionality**: Are 10 dimensions orthogonal, or do they measure overlapping constructs? (E.g., "experimental rigor" and "systematic testing" seem redundant)

**Required changes**:
- Report **when** dimensions were defined (before or after analyzing papers)
- Discuss threats from author serving as rater (knows which papers were panel-driven)
- Add subsection validating dimensions: factor analysis, correlation matrix, predictive validity (if publication outcomes known)
- Acknowledge: Without validation, scores are subjective assessments, not objective metrics

### M3: Review Methodology Confounded with Iteration Count

The paper attributes quality differences to review methodology (traditional vs. panel-driven), but confounds this with **iteration count**. Panel-driven work had 8+ rounds; traditional had 1-2 rounds. The comparison doesn't isolate review *source* (user vs. panel) from review *frequency*.

**Confound**:
- Panel-driven: 8+ rounds, AI reviewers, systematic exploration
- Traditional: 1-2 rounds, user feedback, validation focus

We don't know if traditional papers would improve similarly with 8+ rounds of user-directed iteration. Maybe iteration count matters more than review source?

**Required changes**:
- Acknowledge confound explicitly in limitations (Section 5.3)
- Discuss: How would you isolate review source from iteration count? (e.g., traditional with 8 rounds vs. panel with 8 rounds)
- Qualify claims: "Panel-driven work with 8+ rounds" rather than "panel-driven work" generally
- Future work: Ablation study varying review source and iteration count independently

## Minor Issues

### m1: Process Tracing Is Qualitative, Not Causal

The paper uses git commits and session notes to trace the innovation trajectory (Section 3.3), arguing the panel "drove" the edge-weighting breakthrough. But this is **post-hoc narrative**, not causal evidence. We observe that panel reviews preceded the breakthrough, but correlation ≠ causation. Maybe the breakthrough would have emerged anyway through user-directed exploration.

**Suggestion**: Reframe process tracing as **illustrative examples** of panel-driven mechanisms, not causal proof. Add: "We cannot rule out that traditional workflows might achieve similar breakthroughs with sufficient iteration."

### m2: Score Scale Justification Missing

Why 1-5 scale for quality dimensions? Why not 1-4 (matching reviewer scores) or 1-10 (finer granularity)? The paper doesn't justify the scale choice or discuss its impact on results. With N=1, scale choice could meaningfully affect aggregate scores.

**Suggestion**: Add brief justification for 1-5 scale and discuss sensitivity: Would conclusions change with 1-4 or 1-10 scale?

### m3: Publication Venue Projections Are Speculative

Table 6 (Section 4.4) projects traditional papers to "regional conferences (60-70% acceptance)" and panel-driven to "Science Advances (80-90% acceptance after revision)." These projections are **entirely speculative**—no papers have been submitted. Without actual acceptance data, this is conjecture presented as evidence.

**Suggestion**: Reframe as "hypothetical venue targets based on perceived quality" rather than "projections." Or better, remove the table and discuss venue suitability qualitatively without specific acceptance likelihoods.

### m4: Threats to Validity Section Incomplete

Section 5.3 acknowledges sample size, single author, and domain specificity, but **misses critical threats**:
- N=1 treatment group prevents statistical inference (acknowledged in M1 but not in Section 5.3)
- Quality dimensions not validated (M2)
- Review methodology confounded with iteration count (M3)
- Process tracing is correlational, not causal (m1)

**Suggestion**: Expand Section 5.3 to include all major threats, organized by validity type (internal, external, construct, statistical conclusion).

## Strengths

1. **Within-project design**: Comparing papers from the same project controls for domain, author, model, and temporal factors better than cross-project comparisons. While N=1 limits inference, the design is a reasonable pilot study approach.

2. **Mechanistic analysis**: Section 5.1 identifying four mechanisms (systematic questioning, embracing negatives, standards elevation, iteration forcing) is the paper's strongest contribution. Even without statistical validation, these mechanisms are plausible and actionable.

3. **Process tracing**: Git history and session notes provide valuable qualitative evidence. The Alabama example (Section 4.3) effectively illustrates how panel review transforms failure investigation from "note the limitation" to "systematic exploration."

4. **Honest limitations**: The paper acknowledges single-user, single-domain, and pre-submission limitations. More transparency is needed (see m4), but the existing limitations section is a good start.

5. **Multi-dimensional assessment**: 10 dimensions covering structure, design, maturity, and innovation is more comprehensive than single metrics. While validation is needed, the framework is well-motivated.

## Questions for Authors

1. **Statistical power**: How many papers would you need in each condition to achieve 80% power for detecting a 50% quality difference? (Rough estimate based on your observed variance)

2. **Dimension validation**: Can you show that your 10 dimensions predict external outcomes (publication acceptance, citation impact, expert rankings)?

3. **Iteration ablation**: Have you observed quality improvement from multiple rounds of *user-directed* feedback (no panel)? How does 8-round traditional compare to 8-round panel?

4. **Pre-registration**: Were quality dimensions chosen before analyzing papers, or defined after seeing results?

5. **Replication plan**: What would a properly powered replication look like? M papers in each condition, sufficient for statistical inference?

## Recommendations

- **Reframe as case study** with mechanistic hypotheses rather than empirical evaluation
- **Qualify all quantitative claims** given N=1 (remove certainty, add caveats)
- **Validate quality dimensions** or acknowledge they're subjective assessments
- **Acknowledge iteration count confound** and propose ablation studies
- **Expand threats to validity** to include all major concerns
- **Propose rigorous replication design** in future work section

---

**Verdict**: Major Revisions Required

**Confidence**: High — Evaluation methodology is my core expertise. I'm very confident about statistical and methodological concerns, though less familiar with human-AI collaboration specifics.

---

> **AI Simulation Disclosure**: This review was generated by a large language model
> (Claude, Anthropic) simulating the perspective of the named reviewer. The named
> individual did **not** write or endorse this review. The AI persona is informed by
> the reviewer's published work, known research priorities, and public scholarship,
> but the opinions expressed are synthetic outputs, not the actual views of the
> named researcher. This process is used for pre-submission quality improvement and
> does not represent a real peer review.
